Skip to main content
Clinical Trials/EUCTR2012-004074-25-DE
EUCTR2012-004074-25-DE
Active, not recruiting
Phase 1

Comparison of the efficacy and safety of two different starting dosages of prednisolone in early active rheumatoid arthritis: a randomized, placebo controlled trial - CORRA

Ruhr-Universität Bochum0 sites450 target enrollmentJuly 29, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ruhr-Universität Bochum
Enrollment
450
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 29, 2013
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of rheumatoid arthritis based on expert opinion according to the ACR/EULAR 2009 criteria (Hawker 2009\), disease duration \< 3 years, active disease: DAS 28 ESR (Prevoo et al 1995\) \> 4 plus \= 3 swollen joints
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 225
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 225

Exclusion Criteria

  • Prior treatment with DMARDs (except for hydroxychloroquin or sulfasalazine or methotrexate during the last four weeks before screening)
  • Clinically relevant comorbidity:
  • concurrent liver disease (ALT \> 2 times upper limit of normal),
  • active hepatitis B or C viral infection,
  • renal disease (creatinine clearance \< 30 ml/minute),
  • clinically relevant haematological disease due to the
  • judgement of the rheumatologist,
  • uncontrolled diabetes mellitus,
  • relevant immunodeficiency incl. HIV\-infection,
  • clinically significant pulmonary fibrosis,

Outcomes

Primary Outcomes

Not specified

Similar Trials